Personalized medication for individual needs
Drug compounding generally involves combining, mixing, or altering ingredients to prepare a medication for a particular clinical need. A licensed pharmacist, a licensed physician, or a person working under the direct supervision of a licensed pharmacist in an outsourcing facility may perform compounding when applicable legal requirements are met.
Compounding gives providers an important option when a standard commercially available product does not appropriately meet an individual patient’s needs. A pharmacist may prepare a different dosage form for someone who cannot use the available form, remove an ingredient that causes an allergy, or prepare an individualized strength when clinically appropriate. The treating provider determines whether a compounded option is suitable for the patient.
Why compounding pharmacies matter
Modern medicine is not always one-size-fits-all. Approved medications are manufactured in standardized strengths, dosage forms, and ingredient combinations. Those options serve most patients well, but some patients require an alternative that is not commercially available.
Compounding pharmacies work with prescribers to help fill that gap. Their role can be especially valuable when a patient has an allergy or sensitivity, cannot swallow a particular dosage form, needs an individualized strength, or has another documented clinical need that cannot be met appropriately by an available product.
An important and distinct category of medication
Compounded medications are not FDA-approved. FDA does not conduct premarket review of each compounded medication in the same way it reviews an approved brand-name or generic drug. This regulatory distinction does not mean responsible compounding lacks a legitimate place in care.
Federal and state frameworks recognize the role of compounding while establishing requirements for who may compound, the circumstances in which compounding may occur, facility practices, prescriptions, records, labeling, inspections, and other safeguards. Clear disclosure helps patients understand both the value of personalized medication and how it differs from an FDA-approved manufactured product.
What is a 503A compounding pharmacy?
Section 503A of the Federal Food, Drug, and Cosmetic Act describes conditions under which drug products compounded by a licensed pharmacist in a state-licensed pharmacy or federal facility, or by a licensed physician, may qualify for exemptions from certain federal drug requirements.
503A compounding is generally associated with prescriptions for identified individual patients. State boards of pharmacy have primary responsibility for routine oversight of state-licensed pharmacies, while FDA may conduct surveillance or for-cause inspections and act when federal requirements or insanitary conditions are involved.
A pharmacy license is meaningful, but it should not be described as FDA approval. FDA does not approve or license pharmacies, and a compounded medication prepared by a 503A pharmacy is still not an FDA-approved drug.
What is a 503B outsourcing facility?
Section 503B created a separate category known as outsourcing facilities. These facilities voluntarily register with FDA, must compound under the direct supervision of a licensed pharmacist, and are subject to additional federal requirements, including current good manufacturing practice requirements, adverse-event reporting, and FDA inspection on a risk-based schedule.
Registration is not the same as approval. FDA registration does not mean that every product has been reviewed or that the facility is guaranteed to be compliant at all times. Drugs compounded by 503B outsourcing facilities remain non-FDA-approved.
How are compounding facilities regulated?
Compounding pharmacies operate within a shared system of state and federal oversight. State boards regulate pharmacy licensure and professional practice. FDA administers federal drug law, oversees registered outsourcing facilities, conducts certain inspections, publishes recalls and enforcement information, and works with state regulators.
Depending on the setting, requirements may address prescriptions, ingredients, records, labeling, adverse-event reporting, sterility, facility conditions, distribution, and whether a compounded product is essentially a copy of an available approved medication. These layers of oversight help distinguish legitimate professional compounding from anonymous or unregulated sellers that operate outside established clinical and pharmacy channels.
Questions patients can ask
Patients deserve transparent information about what they are receiving. Reasonable questions include:
- Is this medication FDA-approved or compounded?
- Why is a compounded medication being considered for me?
- What FDA-approved alternatives are available?
- What is the name and location of the dispensing pharmacy or outsourcing facility?
- Is the pharmacy licensed to dispense into my state?
- What instructions apply to storage, use, and disposal?
- What side effects or warning signs should I report?
- What follow-up and laboratory monitoring will be required?
A collaborative model of patient care
Responsible compounding is a collaboration between the patient, treating provider, and pharmacy. The provider evaluates the patient, considers available options, determines whether an individualized prescription is warranted, and establishes an appropriate monitoring plan. The pharmacy prepares and dispenses the prescription within the requirements that apply to its practice.
This partnership allows care to remain individualized while preserving clear professional responsibilities. EverTitan’s public website does not collect medical intake information or guarantee treatment. Clinical eligibility, prescribing decisions, pharmacy selection, and follow-up occur through the treating clinical practice and are determined for each patient.